Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.

Article  Google Scholar 

Zhu J, Li S, Li X, Wang L, Du L, Qiu Y. Impact of population ageing on cancer-related disability-adjusted life years: A global decomposition analysis. J Global Health. 2024;14:04144. https://doi.org/10.7189/jogh.14.04144.

Article  Google Scholar 

Liang Y, Zhang H, Song X, Yang Q. Metastatic heterogeneity of breast cancer: molecular mechanism and potential therapeutic targets. Sem Cancer Biol. 2020;60:14–27. https://doi.org/10.1016/j.semcancer.2019.08.012.

Article  CAS  Google Scholar 

Kabeer F, Tran H, Andronescu M, Singh G, Lee H, Salehi S, Wang B, Biele J, Brimhall J, Gee D, Cerda V, O’Flanagan C, Algara T, Kono T, Beatty S, Zaikova E, Lai D, Lee E, Moore R, Mungall AJ, Aparicio S. Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers. Genome Biol. 2024;25(1):191. https://doi.org/10.1186/s13059-024-03318-3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Monaco ML, Filpi GA, Kohler SL, Eversole R, Idris OA, Essani K. Oncolytic tanapoxvirus recombinants expressing Flagellin C or mouse Interleukin-2 are capable of regressing human Triple-Negative breast cancer xenografts in Immuno-Competent BALB/c nude mice. Pathogens (Basel Switzerland). 2024;13(5):402. https://doi.org/10.3390/pathogens13050402.

Article  CAS  PubMed  Google Scholar 

Tang WJ, Xu D, Liang MX, Wo GQ, Chen WQ, Tang JH, Zhang W. Pitavastatin induces autophagy-dependent ferroptosis in MDA-MB-231 cells via the mevalonate pathway. Heliyon. 2024;10(5):e27084. https://doi.org/10.1016/j.heliyon.2024.e27084.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lim JS, Kim E, Song JS, Ahn S. Energy–stress–mediated activation of AMPK sensitizes MPS1 kinase Inhibition in triple–negative breast cancer. Oncol Rep. 2024;52(2):101. https://doi.org/10.3892/or.2024.8760.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhou H, Li J, He Y, Xia X, Liu J, Xiong H. SLC25A17 inhibits autophagy to promote triple-negative breast cancer tumorigenesis by ROS-mediated JAK2/STAT3 signaling pathway. Cancer Cell Int. 2024;24(1):85. https://doi.org/10.1186/s12935-024-03270-z.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xiao C, Sun Y, Fan J, Nguyen W, Chen S, Long Y, Chen W, Zhu A, Liu B. Engineering Cannabidiol synergistic carbon monoxide nanocomplexes to enhance cancer therapy via excessive autophagy. Acta Pharm Sinica B. 2023;13(11):4591–606. https://doi.org/10.1016/j.apsb.2023.05.019.

Article  CAS  Google Scholar 

Wu L, Lin Y, Gao S, Wang Y, Pan H, Wang Z, Pozzolini M, Yang F, Zhang H, Yang Y, Xiao L, Xu Y. Luteolin inhibits triple-negative breast cancer by inducing apoptosis and autophagy through SGK1-FOXO3a-BNIP3 signaling. Front Pharmacol. 2023;14:1200843. https://doi.org/10.3389/fphar.2023.1200843.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bello I, Smimmo M, d’Emmanuele di Villa Bianca R, Bucci M, Cirino G, Panza E, Brancaleone V. Erucin, an H2S-Releasing Isothiocyanate, exerts anticancer effects in human Triple-Negative breast cancer cells triggering Autophagy-Dependent apoptotic cell death. Int J Mol Sci. 2023;24(7):6764. https://doi.org/10.3390/ijms24076764.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Augello G, Azzolina A, Rossi F, Prencipe F, Mangiatordi GF, Saviano M, Ronga L, Cervello M, Tesauro D. New insights into the behavior of NHC-Gold complexes in cancer cells. Pharmaceutics. 2023;15(2):466. https://doi.org/10.3390/pharmaceutics15020466.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li Y, Jia F, Gao Y, Wang X, Cui X, Pan Z, Wang W, Li M, Lu J, Wu Y. Self-assembled nanocomposites of carboxymethyl β-dextran/protamine sulfate for enhanced chemotherapeutic drug sensitivity of triple-negative breast cancer by autophagy Inhibition via a ternary collaborative strategy. Int J Biol Macromol. 2023;233:123663. https://doi.org/10.1016/j.ijbiomac.2023.123663.

Article  CAS  PubMed  Google Scholar 

Zheng S, Fu W, Huang Q, Zhou J, Lu K, Gu J, Ma R, Guo G. LncRNA PRKCQ-AS1 regulates Paclitaxel resistance in triple-negative breast cancer cells through miR-361-5p/PIK3C3 mediated autophagy. Clin Exp Pharmacol Physiol. 2023;50(6):431–42. https://doi.org/10.1111/1440-1681.13758.

Article  CAS  PubMed  Google Scholar 

Chen JL, Liu ST, Huang SM, Wu ZF. Apoptosis, Proliferation, and autophagy are involved in local Anesthetic-Induced cytotoxicity of human breast cancer cells. Int J Mol Sci. 2022;23(24):15455. https://doi.org/10.3390/ijms232415455.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang FY, Dai SZ, Xu WT, Xiong W, Sun Y, Huang YH, Wang JY, Lin YY, Chen H, Tan GH, Zheng WP. 3’-epi-12β-hydroxyfroside-mediated autophagy degradation of RIPK1/RIPK3 necrosomes leads to anergy of Immunogenic cell death in triple-negative breast cancer cells. Pharmacol Res. 2023;187:106613. https://doi.org/10.1016/j.phrs.2022.106613.

Article  CAS  PubMed  Google Scholar 

Hua F, Xiao YY, Qu XH, Li SS, Zhang K, Zhou C, He JL, Zhu Y, Wan YY, Jiang LP, Tou FF, Han XJ. Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1. Mol Cell Biochem. 2023; 478(7), 1519–31. https://doi.org/10.1007/s11010-022-04597-9

Article  CAS  PubMed  Google Scholar 

Patra I, Naser RH, Hussam F, Hameed NM, Kadhim MM, Ahmad I, Awadh SA, Hamad DA, Parra RMR, Mustafa YF. Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy. Mol Biol Rep. 2023;50(1):85–95. https://doi.org/10.1007/s11033-022-07921-0.

Article  CAS  PubMed  Google Scholar 

Wu M, Huang Q, Liao M, Wu X, Xi H, Ma H, Li S, Zhang Y, Xia Y. OSW-1 induces apoptosis and cyto-protective autophagy, and synergizes with chemotherapy on triple negative breast cancer metastasis. Cell Oncol (Dordrecht Netherlands). 2022;45(6):1255–75. https://doi.org/10.1007/s13402-022-00716-2.

Article  CAS  Google Scholar 

Yen JH, Huang WC, Lin SC, Huang YW, Chio WT, Tsay GJ, Hung MC, Huang ST. Metabolic remodeling in tumor-associated macrophages contributing to antitumor activity of Cryptotanshinone by regulating TRAF6-ASK1 axis. Mol Therapy Oncolytics. 2022;26:158–74. https://doi.org/10.1016/j.omto.2022.06.008.

Article  CAS  Google Scholar 

Pruteanu LL, Braicu C, Módos D, Jurj MA, Raduly LZ, Zănoagă O, Magdo L, Cojocneanu R, Paşca S, Moldovan C, Moldovan AI, Ţigu AB, Gurzău E, Jäntschi L, Bender A, Berindan-Neagoe I. Targeting cell death mechanism specifically in triple negative breast cancer cell lines. Int J Mol Sci. 2022;23(9):4784. https://doi.org/10.3390/ijms23094784.

Article  CAS  PubMed  PubMed Central  Google Scholar 

AlKahlout A, Fardoun M, Mesmar J, Abdallah R, Badran A, Nasser SA, Baydoun S, Kobeissy F, Shaito A, Iratni R, Muhammad K, Baydoun E, Eid AH. Origanum syriacum L. attenuates the malignant phenotype of MDA-MB231 breast cancer cells. Front Oncol. 2022;12:922196. https://doi.org/10.3389/fonc.2022.922196.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pastena P, Perera H, Martinino A, Kartsonis W, Giovinazzo F. Unraveling biomarker signatures in Triple-Negative breast cancer: A systematic review for targeted approaches. Int J Mol Sci. 2024;25(5):2559. https://doi.org/10.3390/ijms25052559.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carvalho FM. Triple-negative breast cancer: from none to multiple therapeutic targets in two decades. Front Oncol. 2023;13:1244781. https://doi.org/10.3389/fonc.2023.1244781.

Article  CAS  PubMed  PubMed Central  Google Scholar 

An G, Liu J, Lin T, He L, He Y. Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis. Front Oncol. 2024;14:1392245. https://doi.org/10.3389/fonc.2024.1392245.

Article  PubMed  PubMed Central  Google Scholar 

Li D, Wu M. Potential value and research frontiers of virus in neuroinflammation: a bibliometric and visualized analysis. Front Immunol. 2024;15:1390149. https://doi.org/10.3389/fimmu.2024.1390149.